A T cell-based immunotherapy designed to target and destroy solid tumor cells by using tumor-specific T cell receptors with enhanced persistence and tumor microenvironment resistance.

A platform to develop off-the-shelf T cell therapies for solid tumors, enabling ready-made treatments without the need for patient-specific cell modification.